Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN785711 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Pleckstrin Homology-Like Domain, Family A, Member 1 (PHLDA1) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- The immunogen for anti-PHLDA1 antibody: synthetic peptide directed towards the C terminal of human PHLDA1
- Description
- Affinity Purified
- Reactivity
- Human, Mouse, Rat, Bovine, Xenopus
- Host
- Rabbit
- Antigen sequence
LAVKSTRQKQQHLVQQQPPSQPQPQPQLQPQPQPQ
PQPQP QPQSQPQPQP- Epitope
- C-Term
- Vial size
- 50 μg
- Concentration
- 1mg/mL
- Storage
- -20°C
- Handling
- Avoid repeated freeze-thaw cycles.
Submitted references Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
Nagai MA, Fregnani JH, Netto MM, Brentani MM, Soares FA
Breast cancer research and treatment 2007 Nov;106(1):49-56
Breast cancer research and treatment 2007 Nov;106(1):49-56
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
Tsuda M, Davis IJ, Argani P, Shukla N, McGill GG, Nagai M, Saito T, Laé M, Fisher DE, Ladanyi M
Cancer research 2007 Feb 1;67(3):919-29
Cancer research 2007 Feb 1;67(3):919-29
No comments: Submit comment
No validations: Submit validation data